SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-069400
Filing Date
2022-06-09
Accepted
2022-06-08 17:31:43
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tm2217743-1_s3.htm S-3 457989
2 EXHIBIT 23.1 tm2217743d2_ex23-1.htm EX-23.1 3343
3 EX-FILING FEES tm2217743d2_ex-filingfees.htm EX-FILING FEES 46630
4 GRAPHIC lg_nrx-4clr.jpg GRAPHIC 44547
5 GRAPHIC tm2217743d2_ex23-1img001.jpg GRAPHIC 2768
6 GRAPHIC tm2217743d2_ex23-1img002.jpg GRAPHIC 2344
  Complete submission text file 0001104659-22-069400.txt   577933
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-265492 | Film No.: 221004336
SIC: 2834 Pharmaceutical Preparations